PUBLICATION
Immunotherapy Targeting the C-Terminal Domain of TDP-43 Decreases Neuropathology and Confers Neuroprotection in Mouse Models of ALS/FTD
INDUSTRY NEWS
2023 Pharma Predictions
INDUSTRY NEWS
PsychoGenics CEO Explores CNS Drug Development Trends
INDUSTRY NEWS
What Will the 2023 Drug Discovery Landscape Look Like?
INDUSTRY NEWS
Executives Shares 7 Life Sciences Predictions to Watch in 2023
INDUSTRY NEWS
Changing Drug Discovery for Neuropsychiatric Disorders with Phenotypic Screens
INDUSTRY NEWS
Why the TAAR1 Agonist Ulotaront Holds Promise for Schizophrenia
INDUSTRY NEWS
Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics
INDUSTRY NEWS
